Cargando…

Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis

OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Shuhua, Zhang, Yu, Xiong, Wenjie, Chen, Weiwei, Hou, Zhaohua, Yang, Yang, Yan, Yuting, Wei, Yunbo, Cui, Rui, Wang, Huijun, Yu, Zhen, Li, Heng, Li, Zengjun, Liu, Wei, Lv, Rui, Wang, Tingyu, Ru, Kun, Zou, Dehui, Shu, Minglei, Qiu, Lugui, Yu, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975127/
https://www.ncbi.nlm.nih.gov/pubmed/31993200
http://dx.doi.org/10.1002/cti2.1105
_version_ 1783490235839021056
author Yi, Shuhua
Zhang, Yu
Xiong, Wenjie
Chen, Weiwei
Hou, Zhaohua
Yang, Yang
Yan, Yuting
Wei, Yunbo
Cui, Rui
Wang, Huijun
Yu, Zhen
Li, Heng
Li, Zengjun
Liu, Wei
Lv, Rui
Wang, Tingyu
Ru, Kun
Zou, Dehui
Shu, Minglei
Qiu, Lugui
Yu, Di
author_facet Yi, Shuhua
Zhang, Yu
Xiong, Wenjie
Chen, Weiwei
Hou, Zhaohua
Yang, Yang
Yan, Yuting
Wei, Yunbo
Cui, Rui
Wang, Huijun
Yu, Zhen
Li, Heng
Li, Zengjun
Liu, Wei
Lv, Rui
Wang, Tingyu
Ru, Kun
Zou, Dehui
Shu, Minglei
Qiu, Lugui
Yu, Di
author_sort Yi, Shuhua
collection PubMed
description OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8(+) cytotoxic T cells (Tc) in 94 BLPD patients and 66 healthy controls. Statistics was utilised to rank T‐cell signatures that distinguished BLPDs from healthy controls and differentially presented between indolent and aggressive categories. RESULTS: By comparing with healthy controls, we found that the indolent but not aggressive type of BLPDs demonstrated a high degree of T‐cell activation, showing the increase in type I helper T (Th1) cells and follicular B‐helper T (Tfh) cells, both of which strongly associated with the enhanced differentiation of exhaustion‐like effector cytotoxic CD8(+) T cells expressing PD‐1 (Tc exhaustion‐like) in indolent BLPDs. Random forest modelling selected a module of T‐cell immune signatures best performing binary classification of all BLPD patients. This signature module was composed of low naïve Th cells and high Th1, Tfh and Tc exhaustion‐like cells which efficiently identified > 85% indolent cases and was, therefore, assigned as the Indolent Dominant Module of T‐cell immune signature. In indolent BLPD patients, a strong bias towards such signatures was found to associate with clinical characteristics of worse prognosis. CONCLUSION: Our study identified a prominent signature of T‐cell dysregulation specifically for indolent BLPDs, suggesting Th1, Tfh and Tc exhaustion‐like cells represent potential prognostic biomarkers and targets for immunotherapies.
format Online
Article
Text
id pubmed-6975127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69751272020-01-28 Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis Yi, Shuhua Zhang, Yu Xiong, Wenjie Chen, Weiwei Hou, Zhaohua Yang, Yang Yan, Yuting Wei, Yunbo Cui, Rui Wang, Huijun Yu, Zhen Li, Heng Li, Zengjun Liu, Wei Lv, Rui Wang, Tingyu Ru, Kun Zou, Dehui Shu, Minglei Qiu, Lugui Yu, Di Clin Transl Immunology Short Communication OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8(+) cytotoxic T cells (Tc) in 94 BLPD patients and 66 healthy controls. Statistics was utilised to rank T‐cell signatures that distinguished BLPDs from healthy controls and differentially presented between indolent and aggressive categories. RESULTS: By comparing with healthy controls, we found that the indolent but not aggressive type of BLPDs demonstrated a high degree of T‐cell activation, showing the increase in type I helper T (Th1) cells and follicular B‐helper T (Tfh) cells, both of which strongly associated with the enhanced differentiation of exhaustion‐like effector cytotoxic CD8(+) T cells expressing PD‐1 (Tc exhaustion‐like) in indolent BLPDs. Random forest modelling selected a module of T‐cell immune signatures best performing binary classification of all BLPD patients. This signature module was composed of low naïve Th cells and high Th1, Tfh and Tc exhaustion‐like cells which efficiently identified > 85% indolent cases and was, therefore, assigned as the Indolent Dominant Module of T‐cell immune signature. In indolent BLPD patients, a strong bias towards such signatures was found to associate with clinical characteristics of worse prognosis. CONCLUSION: Our study identified a prominent signature of T‐cell dysregulation specifically for indolent BLPDs, suggesting Th1, Tfh and Tc exhaustion‐like cells represent potential prognostic biomarkers and targets for immunotherapies. John Wiley and Sons Inc. 2020-01-22 /pmc/articles/PMC6975127/ /pubmed/31993200 http://dx.doi.org/10.1002/cti2.1105 Text en © 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Yi, Shuhua
Zhang, Yu
Xiong, Wenjie
Chen, Weiwei
Hou, Zhaohua
Yang, Yang
Yan, Yuting
Wei, Yunbo
Cui, Rui
Wang, Huijun
Yu, Zhen
Li, Heng
Li, Zengjun
Liu, Wei
Lv, Rui
Wang, Tingyu
Ru, Kun
Zou, Dehui
Shu, Minglei
Qiu, Lugui
Yu, Di
Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title_full Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title_fullStr Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title_full_unstemmed Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title_short Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
title_sort prominent immune signatures of t cells are specifically associated with indolent b‐cell lymphoproliferative disorders and predict prognosis
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975127/
https://www.ncbi.nlm.nih.gov/pubmed/31993200
http://dx.doi.org/10.1002/cti2.1105
work_keys_str_mv AT yishuhua prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT zhangyu prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT xiongwenjie prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT chenweiwei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT houzhaohua prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT yangyang prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT yanyuting prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT weiyunbo prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT cuirui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT wanghuijun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT yuzhen prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT liheng prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT lizengjun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT liuwei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT lvrui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT wangtingyu prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT rukun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT zoudehui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT shuminglei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT qiulugui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis
AT yudi prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis